Gibb D, et al. Impact of raltegravir intensification of first-line art on IRIS in the REALITY trial. CROI 2018. Abstract 23.
Associatie community-acquired fluorochinolonresistente ‘E. coli’ en gebruik van antibiotica in de omgeving
jun 2019 | Antibioticaresistentie